Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126157721 | 12615772 | 1 | I | 20160708 | 20160802 | 20160802 | EXP | CA-HQ SPECIALTY-CA-2016INT000723 | INTERCHEM | POPADIUK C, POWER P. PEGYLATED LIPOSOMAL DOXORUBICIN IS AN ACTIVE AGENT FOR CHEMOTHERAPY-RESISTANT CHORIOCARCINOMA: A REPORT OF TWO CASES. J REPROD MED. 2016;61(5-6):215-8 | 52.00 | YR | F | Y | 0.00000 | 20160802 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126157721 | 12615772 | 1 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | UNK | 0 | |||||||||||
| 126157721 | 12615772 | 2 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Intrathecal | UNK | 0 | ||||||||||
| 126157721 | 12615772 | 3 | PS | CISPLATIN. | CISPLATIN | 1 | UNK | 18057 | |||||||||||
| 126157721 | 12615772 | 4 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | UNK | 0 | |||||||||||
| 126157721 | 12615772 | 5 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | UNK | 0 | |||||||||||
| 126157721 | 12615772 | 6 | SS | ACTINOMYCIN D | DACTINOMYCIN | 1 | UNK | 0 | |||||||||||
| 126157721 | 12615772 | 7 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | UNK | 0 | |||||||||||
| 126157721 | 12615772 | 8 | SS | TAXOL | PACLITAXEL | 1 | UNK | 0 | |||||||||||
| 126157721 | 12615772 | 9 | SS | PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | 1 | 35 MG/M2 | 0 | 35 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126157721 | 12615772 | 1 | Product used for unknown indication |
| 126157721 | 12615772 | 3 | Product used for unknown indication |
| 126157721 | 12615772 | 4 | Product used for unknown indication |
| 126157721 | 12615772 | 5 | Product used for unknown indication |
| 126157721 | 12615772 | 6 | Product used for unknown indication |
| 126157721 | 12615772 | 7 | Product used for unknown indication |
| 126157721 | 12615772 | 8 | Product used for unknown indication |
| 126157721 | 12615772 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126157721 | 12615772 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126157721 | 12615772 | Gestational trophoblastic tumour | |
| 126157721 | 12615772 | Human chorionic gonadotropin increased | |
| 126157721 | 12615772 | Metastases to central nervous system | |
| 126157721 | 12615772 | Sepsis | |
| 126157721 | 12615772 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |